900503-08-4 Usage
General Description
Tert-butyl 3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-8-azabicyclo[3.2.1]oct-3-ene-8-carboxylate is a chemical compound that belongs to the class of organic esters. It is commonly used as a reagent in organic synthesis and as a building block in the production of pharmaceuticals and agrochemicals. tert-butyl 3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-8-azabicyclo[3.2.1]oct-3-ene-8-carboxylate is known for its high stability and is often used in the creation of complex organic molecules. It is important in the field of organic chemistry due to its structural complexity and its usefulness in creating diverse chemical structures.
Check Digit Verification of cas no
The CAS Registry Mumber 900503-08-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,0,0,5,0 and 3 respectively; the second part has 2 digits, 0 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 900503-08:
(8*9)+(7*0)+(6*0)+(5*5)+(4*0)+(3*3)+(2*0)+(1*8)=114
114 % 10 = 4
So 900503-08-4 is a valid CAS Registry Number.
InChI:InChI=1/C18H30BNO4/c1-16(2,3)22-15(21)20-13-8-9-14(20)11-12(10-13)19-23-17(4,5)18(6,7)24-19/h10,13-14H,8-9,11H2,1-7H3
900503-08-4Relevant articles and documents
Compound and application thereof
-
, (2019/04/17)
The invention provides a novel compound. The novel compound has certain inhibitory activity for indoleamine 2,3-dioxygenase (IDO) which is oxido-reductase, and accordingly the novel compound can be used for treating diseases related to the indoleamine 2,3-dioxygenase and can be applied to cancer and immunity related diseases.
TETRAHYDROPYRIDO[4,3-D]PYRIMIDINE INHIBITORS OF ATR KINASE
-
, (2018/12/13)
The present invention relates to tetrahydropyrido[4,3-d]pyrimidine based compounds and methods which may be useful as inhibitors of ATR kinase for the treatment or prevention of cancer.
Imidazopyrazine Derivatives as Modulators of TNF Activity
-
Paragraph 0476, (2015/07/15)
A series of imidazo[1,2-α]pyrazine derivatives, being potent modulators of human TNFα activity, are accordingly of benefit in the treatment and/or prevention of various human ailments, including autoimmune and inflammatory disorders; neurological and neurodegenerative disorders; pain and nociceptive disorders; cardiovascular disorders; metabolic disorders; ocular disorder; and oncological disorders.